FDA
approval
· 2022-07-28
FDA Approved: DALFAMPRIDINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
The FDA approved a supplemental application for dalfampridine from Sun Pharmaceutical Industries, Inc. (ANDA208292), supporting the generic version of the produ…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)